Corporate Events

Xebio Holdings Co., Ltd. provided consolidated earnings guidance for the six months ending September 30, 2026 and fiscal year ending March 31, 2027. For six months, the company expects net sales of JPY 131,100 million, operating profit of JPY 3,100 million, profit attributable to owners of parent of JPY 2,300 million and basic earnings per share of JPY 53.52. For the fiscal year, the company expects net sales of JPY 264,600 million, operating profit of JPY 7,000 million, profit attributable to owners of parent of JPY 7,500 million and basic earnings per share of JPY 174.54.

Xebio Holdings Co., Ltd. provided dividend guidance for the second quarter-end and fiscal year-end of year ending March 31, 2027. For the quarter, the company expects dividend of JPY 17.50 per share compared to JPY 17.50 per share a year ago. For the year, the company expects dividend of JPY 17.50 per share compared to JPY 17.50 per share a year ago.

Xebio Holdings Co., Ltd., Board Meeting, Aug 18, 2026. Agenda: To consider the Notice Concerning the Allotment of Stock Acquisition Rights as Stock-Based Compensation-Type Stock Options to Directors.

Xebio Holdings Co., Ltd., ¥ 17.5, Cash Dividend, Sep-29-2026

Xebio Holdings Co., Ltd., Board Meeting, Jun 05, 2026. Agenda: To consider and determine the Terms and Conditions for the Issuance of Stock Acquisition Rights as Stock Options.

Xebio Holdings Co., Ltd. (TSE:8281) signed a letter of intent to acquire Nedai Pty. Ltd. on May 15, 2026. The transaction is subject to approval of offer by acquirer board, subject to the finalization of the share transfer agreement and conditions precedent, including the reorganization of the Drummond Golf Group. The expected completion of the transaction is April 1, 2027 to April 30, 2027.

Xebio Holdings Co., Ltd., Annual General Meeting, Jun 26, 2026.

Xebio Holdings Co., Ltd., Board Meeting, May 15, 2026. Agenda: To consider acquisition of shares of Drummond Golf Pty Ltd in AAustralia and conversion into a subsidiary.

Xebio Holdings Co., Ltd. announced that they will report Q1, 2027 results on Aug 14, 2026

Xebio Holdings Co., Ltd. announced that they will report fiscal year 2026 results at 12:00 PM, Tokyo Standard Time on May 09, 2026

Xebio Holdings Co., Ltd., Board Meeting, May 01, 2026. Agenda: To Notice Concerning the Recording of Extraordinary Loss and Revision to Full-Year Financial Results Forecasts.

Xebio Holdings Co., Ltd., Board Meeting, Apr 21, 2026. Agenda: To consider and approve the Change of Representative, Changes in Directors (Effective June 26, 2026).

Xebio Holdings Co., Ltd. reported earnings results for the nine months ended December 31, 2025. For the nine months, the company reported sales was JPY 188,803 million compared to JPY 188,258 million a year ago. Net income was JPY 866 million compared to JPY 3,925 million a year ago. Basic earnings per share from continuing operations was JPY 20.93 compared to JPY 90.6 a year ago.

Xebio Holdings Co., Ltd. expected to report Fiscal Year 2026 results on May 8, 2026. This event was calculated by S&P Global (Created on February 13, 2026).

Xebio Holdings Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026

Xebio Holdings Co., Ltd. revised consolidated earnings guidance for the fiscal year ending March 31, 2026. For the fiscal year ending March 31, 2026, the company now expects net sales of JPY 253,534 million, operating profit of JPY 4,017 million, profit attributable to owners of parent of JPY 236 million, basic earnings per share of JPY 5.49 against previous guidance of net sales of JPY 264,305 million, operating profit of JPY 7,223 million, profit attributable to owners of parent of JPY 974 million, basic earnings per share of JPY 22.66 . The revision of the full-year earnings forecast is primarily due to the differences identified in the consolidated results for the second quarter of FY2026. In addition, given the uncertain outlook for a rapid recovery in consumer spending in the second half of the fiscal year, operating profit, ordinary profit, and net income attributable to owners of the parent are all expected to fall below the previously announced forecast. Accordingly, the Company has revised its full-year consolidated earnings forecast for FY2026.

Xebio Holdings Co., Ltd. announced cash dividend of JPY 17.50 per share for the Second quarter-end of fiscal year ending March 31, 2026 against dividend of JPY 15.00 per share a year ago. Scheduled date to commence dividend payments: December 11, 2025.

Xebio Holdings Co., Ltd., ¥ 17.5, Cash Dividend, Mar-30-2026

Xebio Holdings Co., Ltd. expected to report Q3 2026 results on February 13, 2026. This event was calculated by S&P Global (Created on November 14, 2025).

Xebio Holdings Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025